Since
the discovery of l-glutamate-producing Corynebacterium
glutamicum, it has evolved to be
an industrial workhorse. For biobased chemical production, suppling
sufficient amounts of the NADPH cofactor is crucial. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), a glycolytic enzyme that converts glyceraldehyde-3-phosphate
(G3P) to 1,3-bisphosphoglycerate and produces NADH, is a major prospective
solution for the cofactor imbalance issue. In this study, we determined
the crystal structure of GAPDH from C. glutamicum ATCC13032 (CgGAPDH). Based on the structural information,
we generated six CgGAPDH variants, CgGAPDHL36S, CgGAPDHL36S/T37K, CgGAPDHL36S/T37K/P192S, CgGAPDHL36S/T37K/F100V/P192S, CgGAPDHL36S/T37K/F100L/P192S, and CgGAPDHL36S/T37K/F100I/P192S, that can produce both NADH and NAPDH. The final CgGAPDHL36S/T37K/F100V/P192S variant showed a 212-fold increase
in enzyme activity for NADP as well as 200% and 30% increased activity
for the G3P substrate under NAD and NADP cofactor conditions, respectively.
In addition, crystal structures of CgGAPDH variants
in complex with NAD(P) permit the elucidation of differences between
wild-type CgGAPDH and variants in relation to cofactor
stabilization.